Drug Type Small molecule drug |
Synonyms- |
Mechanism p300-CBP transcription factors inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H28N6S |
InChIKeyVKWQTYSHJWGMAZ-UHFFFAOYSA-N |
CAS Registry2439065-66-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Preclinical | CN | 28 Jun 2019 |